pT3-EF1A-MYC-IRES-luc Citations (3)

Originally described in: beta-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma.
Ruiz de Galarreta M, Bresnahan E, Molina-Sanchez P, Lindblad KE, Maier B, Sia D, Puigvehi M, Miguela V, Casanova-Acebes M, Dhainaut M, Villacorta-Martin C, Singhi AD, Moghe A, von Felden J, Tal Grinspan L, Wang S, Kamphorst AO, Monga SP, Brown BD, Villanueva A, Llovet JM, Merad M, Lujambio A Cancer Discov. 2019 Jun 11. pii: 2159-8290.CD-19-0074. doi: 10.1158/2159-8290.CD-19-0074. PubMed Journal

---

Articles Citing pT3-EF1A-MYC-IRES-luc

Articles
The portrait of liver cancer is shaped by mitochondrial genetics. Chattopadhyay M, Jenkins EC, Lechuga-Vieco AV, Nie K, Fiel MI, Rialdi A, Guccione E, Enriquez JA, Sia D, Lujambio A, Germain D. Cell Rep. 2022 Jan 18;38(3):110254. doi: 10.1016/j.celrep.2021.110254. PubMed
Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy. Ghasemi A, Martinez-Usatorre A, Li L, Hicham M, Guichard A, Marcone R, Fournier N, Torchia B, Martinez Bedoya D, Davanture S, Fernandez-Vaquero M, Fan C, Janzen J, Mohammadzadeh Y, Genolet R, Mansouri N, Wenes M, Migliorini D, Heikenwalder M, De Palma M. Nat Cancer. 2024 Feb;5(2):240-261. doi: 10.1038/s43018-023-00668-y. Epub 2023 Nov 23. PubMed
LncRNA CRNDE Drives the Progression of Hepatocellular Carcinoma by inducing the Immunosuppressive Niche. Li X, Liang S, Fei M, Ma K, Sun L, Liu Y, Liu L, Wang J. Int J Biol Sci. 2024 Jan 1;20(2):718-732. doi: 10.7150/ijbs.85471. eCollection 2024. PubMed

If you have published an article using this material, please email us at to have your article added to this page.